FDA Allows Keratome Manufacturers To Add LASIK Labeling Immediately
This article was originally published in The Gray Sheet
Executive Summary
Keratome manufacturers may label their devices specifically for use in laser-assisted in situ keratomileusis (LASIK) procedures immediately, provided their previously cleared 510(k) meets several criteria outlined in FDA's June 21 guidance